CORTEXA
← Browse
openalexFrontiers in Gastroenterology2026-07-24Cited by 0

Congenital hepatic fibrosis in an adult female combined with Von Meyenburg complex and autosomal dominant polycystic kidney disease: a case report

Xinrui Ren, Yu Cui, Jiayi Song, Yiwen Tang, X C Xie, Wanchun Zhu, Zhuo Yu, Lingying Huang, Gao Y

Background Congenital hepatic fibrosis (CHF) is a rare disease associated with the polycystic kidney gene, and the initial symptoms are often associated with portal hypertension, such as splenomegaly and esophageal varices. While the basic clinical features and pathogenesis of isolated CHF have been thoroughly studied, patients frequently present variable combined phenotypes including autosomal dominant polycystic kidney disease (ADPKD) and Von Meyenburg complex (VMC). The pathogenic mechanisms driving these composite phenotypes require further exploration. Methods and results We report a case of an adult female patient who was admitted due to unexplained upper gastrointestinal bleeding. Upon admission, the patient was diagnosed with congenital hepatic fibrosis in conjunction with VMC and ADPKD, based on findings from liver puncture biopsy, exome sequencing (ES), biochemical tests, and imaging examinations. Conclusions The PKD1 gene is the causative gene for this patient’s CHF combined with VMC and ADPKD.

View free PDFSource page

Related papers

openalexFrontiers in Gastroenterology2026-07-23

Clinical study on the screening of biomarkers for Crohn’s disease based on blood metabolomics

Tongyuan Lin, Xianhong Hu, Kaifei Yuan, SiYuan Li, Ping Lin, Wang Wj, et al.

Background Crohn’s disease (CD) is a chronic inflammatory condition that affects the gastrointestinal tract. Currently, the diagnosis of CD is predominantly dependent on endoscopic procedures and histopathological tissue analysis. Endoscopy is an invasive procedure, patient compl…

View free PDFSource page
openalexFrontiers in Gastroenterology2026-07-23

A real-world assessment of healthcare resource utilization following IBS-Smart ® and Trio-Smart ® testing in patients with suspected irritable bowel syndrome

Leonard Weinstock, William B. Salt, Lynn Cherry, Christopher Tyson, Raf Magar

Background IBS is a disorder of gut-brain interaction that is diagnosed positively but still requires a focused differential diagnosis and limited rule-out testing. IBS-Smart and Trio-Smart are commercially available serologic and breath tests that may alter diagnostic sequencing…

View free PDFSource page